BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Copernicus Group IRB Corporate Trainer Speaking at Barnett Clinical Summit


10/9/2012 1:07:37 PM

October 9, 2012, Research Triangle Park – Copernicus Group IRB (CGIRB), a leading independent institutional review board, announced today that Corporate Trainer Sydney Douglas will be speaking at this week’s Barnett Clinical Summit in Cambridge, Mass.

The four-day summit, which begins today, is a premier information-sharing forum covering issues of key importance to clinical research professionals. The event includes formal presentations from leading experts, case studies, breakout discussion groups and workshops.

Ms. Douglas’ presentation, “Understanding the Importance of Training in Minimizing Clinical Research Risk,” scheduled for 3:30 p.m. Oct. 12, is included in the summit’s Clinical Training Forum track. The presentation will explain how training has become a key factor in minimizing clinical research risk, particularly from an IRB perspective, including organizational benefits, metrics as support to implementing effective training programs, and three ways to ensure training best practices.

“Training initiatives play a significant role in the clinical research process, and best practices are imperative,” Ms. Douglas said. “The Barnett Clinical Summit presents an opportunity for clinical research professionals to learn more about current technologies, processes, and best practices that can be applied across their organizations’ training programs.”

After joining CGIRB in 2007, Sydney Douglas was responsible for providing training during CGIRB’s transformation from a paper-based company into a paperless organization. Additionally, she manages the corporate training program and facilitates training related to accreditation and certification. Ms. Douglas’ efforts earned CGIRB’s training program national recognition as a 2012 Training Top 125 company.

For more information, visit cgirb.com. For more information on the Barnett Clinical Training Forum, visit http://www.barnettclinicalsummit.com/clinicaltraining/

About Copernicus Group IRB

Experience and innovation in ethical review®

Copernicus Group IRB, established in July 1996, is a leading U.S. independent institutional review board (“IRB”) dedicated to ensuring the rights and welfare of research study participants. The IRB provides ethical review of research protocols, investigators, and subject information and consent forms to ensure compliance with federal regulations set forth in 21 CFR, 45 CFR and ICH/GCP Guidelines. CGIRB achieved full AAHRPP accreditation in 2004, reaccreditation in 2007 and 2011, and ISO 9001:2008 certification in 2010. For more information please visit http://www.cgirb.com

About Barnett International

Founded in 1979, Barnett International is widely recognized for its superior consulting services and its targeted education and training programs. Barnett helps clients get the most out of their research and development dollars by managing change effectively, improving organizational performance, and enhancing staff knowledge. The Barnett approach is a unique combination of strategy development and practical, hands-on implementation. The "Barnett Difference" is evident in our deep understanding of the clinical research process and in the rapid and tangible performance improvements we deliver.

We help pharmaceutical, biotechnology and medical device companies maximize the speed and quality of their product development efforts. With an international presence and many staff members working from the client site for increased benefits, Barnett is able to apply a global expertise to its projects. Our services include educational programs and products as well as consulting services. For more information, visit www.barnettinternational.com.

Corporate Contact:

Rebecca Sipes

rsipes@cgirb.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES